IBA BUSINESS UPDATE - THIRD QUARTER 2018
(WorldNews Belgium)

Louvain-La-Neuve, Belgium, 15 November 2018 - IBA (Ion Beam Applications S.A., EURONEXT), the world`s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update for the third quarter ending 30 September 2018. 21 international proton therapy projects ongoing, comprising 13 Proteus®ONE and eight Proteus®PLUS. Proteus®ONE sold in Singapore, representing the first contract for this solution in South East Asia and bringing the total sold year-to-date to six -three contracts are awaiting financing and one is a term sheet with down payment. IBA`s pipeline of new prospective customers considering investment in proton therapy continues to increase in...